{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:09:50Z","timestamp":1788343790372,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"abstract":"<jats:p>\n                    To assess the association between insulin regimens and health-related quality of life (HRQoL) after the introduction of basal insulin (BI) among people with type 2 diabetes in real-world clinical settings. 16,339 registered people with diabetes who had inadequate glycaemic control by oral agents initiated BI (either single BI or Basal-bolus) and completed a 6-month follow-up from 209 hospitals were included in the analyses. At the end of the follow-up, the switches of insulin regimens, change of HRQoL (EQ-5D-3L) and their associations were assessed. Initial insulin regimens of single BI and of basal-bolus (BI included Glargine, Detemir, and Neutral Protamine Hagedorn) accounted for 75.6% and 24.4%, respectively. At 6 months, regimens used were BI alone (65.2%), basal-bolus (10.4%), and premixed (6.4%), whereas 17.9% stopped all insulin therapy. The visual analogue scale score increased by 5.46 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .001), and the index value increased slightly by 0.02 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .001). Univariate analysis showed that people with diabetes taking basal-bolus regimen had the greatest improvement on HRQoL in all dimensions, especially in the reduction of the percentage of Pain\/Discomfort (by 10.03%) and Anxiety\/Depression (by 11.21%). In multivariable analysis, single BI or premixed insulin at 6 months was associated with more improvement of visual analogue scale score compared with stopping all insulin. Improved HRQoL was observed after initiating BI in people with type 2 diabetes . If the same achievement on HbA1c control can be guaranteed, single BI is preferred to other regimens from the viewpoint of HRQoL. Basal-bolus has the most significant potential to increase HRQoL, however, the people with diabetes characteristics differ from those initiating BI alone. Further longitudinal cohort study with a longer study period might be necessary to evaluate the certain effect.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000034718","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T18:00:46Z","timestamp":1693418446000},"page":"e34718","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes"],"prefix":"10.1097","volume":"102","author":[{"given":"Puhong","family":"Zhang","sequence":"first","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"},{"name":"The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshan","family":"Zhu","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"},{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachao","family":"Ji","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin B.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Peers for Progress and Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"},{"name":"WHO Collaborating Centre on Implementation Research for Prevention and Control of Noncommunicable Diseases, Melbourne, VIC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadila","family":"Duolikun","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du","family":"Wang","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1463-1326.2008.00981.x","article-title":"Insulin therapy in type 2 diabetes: what is the evidence?","volume":"11","author":"van Avendonk","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4158\/EP.10.6.502","article-title":"Impact of improved glycemic control on quality of life in patients with diabetes.","volume":"10","author":"Jacobson","year":"2004","journal-title":"Endocr Pract"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.diabres.2007.03.021","article-title":"Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.","volume":"78","author":"Houlden","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2337\/dc06-1712","article-title":"Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.","volume":"30","author":"Vinik","year":"2007","journal-title":"Diabetes Care"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2337\/diacare.25.3.458","article-title":"Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes.","volume":"25","author":"Redekop","year":"2002","journal-title":"Diabetes Care"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1185\/030079905X61929","article-title":"Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes.","volume":"21","author":"Davis","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1464-5491.2011.03416.x","article-title":"The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review.","volume":"29","author":"Barendse","year":"2012","journal-title":"Diabet Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1520-7560(199905\/06)15:3<205::AID-DMRR29>3.0.CO;2-O","article-title":"Quality of life and diabetes.","volume":"15","author":"Rubin","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/MLR.0b013e3180618b55","article-title":"The effects of interventions on health-related quality of life among persons with diabetes: a systematic review.","volume":"45","author":"Zhang","year":"2007","journal-title":"Med Care"},{"issue":"Suppl 1","key":"R10-20250504","first-page":"S4","article-title":"Insulin therapy and quality of life. A review.","volume":"25","author":"Pouwer","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1525-1497.2005.0117.x","article-title":"Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens.","volume":"20","author":"Vijan","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","article-title":"Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"R13-20250504","first-page":"33","article-title":"Psychological insulin resistance in patients with type 2 diabetes.","volume":"63","author":"Jha","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/03007995.2016.1248911","article-title":"Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization.","volume":"33","author":"Dalal","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1464-5491.2011.03329.x","article-title":"Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.","volume":"28","author":"Hajos","year":"2011","journal-title":"Diabet Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.diabres.2011.10.020","article-title":"Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: results from the A1chieve observational study.","volume":"94","author":"Shah","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11136-011-0051-0","article-title":"The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care.","volume":"21","author":"Hajos","year":"2012","journal-title":"Qual Life Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/dia.2015.0054","article-title":"Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled by oral hypoglycemic agents in China \u2013 study design and baseline characteristics.","volume":"17","author":"Ji","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11136-004-0612-6","article-title":"Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China.","volume":"14","author":"Wang","year":"2005","journal-title":"Qual Life Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11136-011-9915-6","article-title":"Validation of the EQ-5D in a general population sample in urban China.","volume":"21","author":"Wang","year":"2012","journal-title":"Qual Life Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jval.2014.05.007","article-title":"Chinese time trade-off values for EQ-5D health states.","volume":"17","author":"Liu","year":"2014","journal-title":"Value Health"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.2930","article-title":"The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity.","volume":"23","author":"Alva","year":"2014","journal-title":"Health Econ"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/ijcp.12133","article-title":"Resource utilisation and quality of life following initiation of insulin detemir in patients with type 2 diabetes mellitus.","volume":"67","author":"Liebl","year":"2013","journal-title":"Int J Clin Pract"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17446651.2023.2204941","article-title":"Treatment of type 2 diabetes patients with heart conditions.","volume":"18","author":"Aktas","year":"2023","journal-title":"Expert Rev Endocrinol Metab"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-006-0249-9","article-title":"Correlates of health-related quality of life in type 2 diabetes.","volume":"49","author":"Wexler","year":"2006","journal-title":"Diabetologia"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc13-1928","article-title":"Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.","volume":"37","author":"Rubin","year":"2014","journal-title":"Diabetes Care"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/dc06-2571","article-title":"Clustering of multiple healthy lifestyle habits and health-related quality of life among U.S. adults with diabetes.","volume":"30","author":"Li","year":"2007","journal-title":"Diabetes Care"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/0145721711436132","article-title":"Diabetes-specific quality of life after a low-carbohydrate and low-fat dietary intervention.","volume":"38","author":"Davis","year":"2012","journal-title":"Diabetes Educ"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diabres.2014.08.032","article-title":"Randomization to a low-carbohydrate diet advice improves health related quality of life compared with a low-fat diet at similar weight-loss in Type 2 diabetes mellitus.","volume":"106","author":"Guldbrand","year":"2014","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:02:12Z","timestamp":1746313332000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":30,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034718","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}